NasdaqCM - Nasdaq Real Time Price USD
Marker Therapeutics, Inc. (MRKR)
1.2500
+0.0600
+(5.04%)
As of 12:19:52 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-10,910.3240
-10,910.3240
-16,439.9610
-26,972.1530
-27,279.7650
Investing Cash Flow
--
--
18,664.1220
-4,945.1360
-3,131.1310
Financing Cash Flow
14,991.3140
14,991.3140
1,105.1170
202.1300
52,555.8450
End Cash Position
19,192.4400
19,192.4400
15,111.4500
11,782.1720
43,497.3310
Capital Expenditure
--
--
--
-4,945.1360
-3,131.1310
Issuance of Capital Stock
14,929.1550
14,929.1550
1,014.6400
202.1300
52,552.7580
Free Cash Flow
-10,910.3240
-10,910.3240
-16,439.9610
-26,972.1530
-30,410.8960
12/31/2021 - 7/16/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DSGN Design Therapeutics, Inc.
4.1400
+1.72%
NTRB Nutriband Inc.
5.40
+3.65%
RAPT RAPT Therapeutics, Inc.
0.8629
-0.20%
ATXI Avenue Therapeutics, Inc.
0.2580
-4.44%
NTHI NeOnc Technologies Holdings, Inc. Common Stock
5.74
-2.41%
VYNE VYNE Therapeutics Inc.
1.8890
+2.66%
REVB Revelation Biosciences, Inc.
2.8500
+0.71%
BDRX Biodexa Pharmaceuticals Plc
1.5000
+5.63%
PMVP PMV Pharmaceuticals, Inc.
1.0700
0.00%
GHRS GH Research PLC
9.53
+0.32%